This came after Johnson and Johnson presented the proposal for approval of additional indication i.e, for the treatment of ...

NDAQ:LEGN) Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Dose modification should only be used because of toxicity; when modified appropriately, bortezomib remains active and the intensity of adverse effects can be reduced.

Background/Rationale: The combination of the proteosome inhibitor bortezomib (B) and purine analog clofarabine (C) induced synergy in the NCI-ALMANAC screen of FDA-approved cancer drug combinations; ...

Systemic racism adds wattage to the problem of inequality in healthcare. It often starts with a not uncommon tendency for healthcare providers to be dismissive of their Black patients’ concerns ...

Stem cell therapies are a type of cell therapy in which the cells used are either stem cells (as in the case of bone marrow transplantation) or are derived from stem cells, as is this case with ...